Allurion Technologies Inc (ALUR) Stock Price, Quote & News

Company Profile

Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform offers the Allurion Program, a swallowable and procedure-less intragastric balloon for weight loss, as well as provides access to artificial intelligence-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. The company operates in Spain, France, Tur...

Industry: Medical Devices

Sector: Healthcare

Phone: 508 647 4000

Website: www.allurion.com

Address:

11 Huron Drive, Natick, United States

Cattitude Jun. 26 at 11:00 PM

$ALUR sleeper 😎

0 · Reply

Blackberrry Jun. 25 at 10:21 PM

$ALUR what was that 150k share candle near the close? 🤔

1 · Reply

Dani_G_German Jun. 25 at 7:55 PM

$ALUR 👀

0 · Reply

Cattitude Jun. 25 at 7:52 PM

$ALUR lovely green candle 😎

0 · Reply

Cattitude Jun. 25 at 7:45 PM

$ALUR fda coming soon, idk if any of you listened last week at the conference, but they sounded super ready for launching in the us, was very intriguing and not to mention the insider buys 😎

1 · Reply

Stonehenge52 Jun. 25 at 4:06 PM

$ALUR always love these red days. Shorting is the only way with these medical stocks

1 · Reply

RollingDollars Jun. 23 at 7:15 PM

$ALUR

0 · Reply

KNCourt24 Jun. 23 at 4:21 PM

$ALUR Gonna have patience with this one EOM final module submission to FDA

0 · Reply

Stonehenge52 Jun. 20 at 8:20 PM

$ALUR any of yall starting to catch on yet?

0 · Reply

Stonehenge52 Jun. 20 at 2:25 PM

$ALUR medical stocks will almost certainly print you money if you short them.

0 · Reply

Allurion Announces Findings from New Studies on Muscle Mass Maintenance in Nearly 20,000 Patients and Four-Year Weight Loss Outcomes at the 2025 Annual Meeting of the ASMBS

May 29, 2025, 4:05 PM EDT - 4 weeks ago

Allurion to Present at Jefferies Global Healthcare Conference

May 27, 2025, 4:05 PM EDT - 4 weeks ago

Allurion Presents Data on Increasing Muscle Mass and Decreasing Fat Mass in Patients Treated With the Allurion Program

May 14, 2025, 2:44 PM EDT - 6 weeks ago

Allurion Technologies Inc. (ALUR) Q1 2025 Earnings Call Transcript

May 14, 2025, 8:00 AM EDT - 6 weeks ago

Allurion Reports First Quarter 2025 Financial Results and Provides Business Update

May 13, 2025, 4:05 PM EDT - 6 weeks ago

Allurion Presents Data on the Allurion Balloon and AI-Powered Virtual Care Suite with and without GLP-1s to Optimize Muscle Mass and Increase Weight Loss

May 5, 2025, 4:05 PM EDT - 7 weeks ago

Allurion to Report First Quarter 2025 Financial Results on May 14, 2025

Apr 3, 2025, 4:30 PM EDT - 3 months ago

Allurion Announces Postponement of Special Meeting of Stockholders

Mar 26, 2025, 10:44 AM EDT - 3 months ago

Allurion Technologies Inc. (ALUR) Q4 2024 Earnings Call Transcript

Mar 26, 2025, 8:00 AM EDT - 3 months ago

Allurion Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update

Mar 20, 2025, 4:05 PM EDT - 3 months ago

Allurion Announces Initial Results on the Combination of the Allurion Program With Low-dose GLP-1 Therapy to Optimize Muscle Mass and GLP-1 Adherence

Mar 12, 2025, 4:05 PM EDT - 3 months ago

Allurion to Report Fourth Quarter 2024 Financial Results on March 26, 2025

Mar 4, 2025, 4:05 PM EST - 4 months ago

Allurion Announces Notification of Issuance of New U.S. Patents on Next-Generation Weight Loss Device for the Treatment of Obesity

Feb 25, 2025, 4:05 PM EST - 4 months ago

Allurion to Participate in Upcoming Investor Conferences

Feb 20, 2025, 4:05 PM EST - 4 months ago

Allurion Announces Closing of Offering and Concurrent Private Placement to Advance GLP-1 Clinical Pipeline

Feb 19, 2025, 9:03 AM EST - 4 months ago

Allurion to Raise Approximately $6.1 Million of Gross Proceeds in Offering and Concurrent Private Placement to Advance GLP-1 Clinical Pipeline

Feb 18, 2025, 8:30 AM EST - 4 months ago

Allurion Announces Plans To Combine GLP-1 Therapy With The Allurion Balloon to Treat Obesity

Feb 13, 2025, 8:30 AM EST - 4 months ago

Allurion Relaunches in France

Jan 24, 2025, 1:25 PM EST - 5 months ago

Allurion Technologies Shares Are Up Today: What's Going On?

Jan 24, 2025, 11:50 AM EST - 5 months ago

Allurion Stock Triples on Plan to Test Gastric Balloon With Obesity Drugs

Jan 24, 2025, 9:30 AM EST - 5 months ago

Allurion to Raise Approximately $7.4 Million of Gross Proceeds in Offering Priced At-the-Market

Jan 23, 2025, 3:48 PM EST - 5 months ago

Allurion Announces Plans To Optimize Muscle Mass During GLP-1 Therapy In Combination With the Allurion Program

Jan 21, 2025, 8:30 AM EST - 5 months ago

Allurion Announces Notification of Issuance of New U.S. Patent on Next-Generation Weight Loss Device for the Treatment of Obesity

Jan 14, 2025, 9:18 AM EST - 5 months ago

Allurion Announces Private Placement of Common Stock and Preliminary Unaudited Financial Results for the Fourth Quarter and Fiscal Year 2024

Jan 8, 2025, 8:00 AM EST - 6 months ago

Allurion Announces Positive Topline Results From AUDACITY Trial

Dec 24, 2024, 7:00 AM EST - 6 months ago

Allurion Technologies, Inc. Announces Reverse Stock Split

Dec 2, 2024, 8:00 AM EST - 7 months ago

Allurion Announces NYSE Acceptance of Plan to Regain Listing Compliance

Nov 25, 2024, 8:00 AM EST - 7 months ago

Allurion Launches in the US with its First AI-Native Compounded GLP-1 Program

Nov 13, 2024, 12:43 PM EST - 8 months ago

Allurion Technologies Inc. (ALUR) Q3 2024 Earnings Call Transcript

Nov 13, 2024, 8:00 AM EST - 8 months ago

Allurion Reports Third Quarter 2024 Financial Results and Provides Business Update

Nov 4, 2024, 8:10 AM EST - 8 months ago

Allurion Presents Data From Largest Ever Real-World Experience of 19,428 Patients at The Obesity Society's Annual Conference

Oct 30, 2024, 8:30 AM EDT - 8 months ago

Allurion to Report Third Quarter 2024 Financial Results on November 13, 2024

Oct 23, 2024, 8:00 AM EDT - 8 months ago

Allurion Announces Submission of First Three Modules of Premarket Approval Application to the U.S. Food and Drug Administration for the Allurion Balloon

Oct 9, 2024, 1:46 PM EDT - 9 months ago

October's 4 Best Penny Stocks: High-Risk, High-Reward Picks

GEVO KULR LUCD

Oct 9, 2024, 8:00 AM EDT - 9 months ago

Allurion Announces Publication of New Data Demonstrating Muscle Mass Preservation in Patients Experiencing 15% Weight Loss

Oct 1, 2024, 8:04 AM EDT - 9 months ago

Allurion Announces Publication of Meta-Analysis Demonstrating the Safety and Effectiveness of the Allurion Program for Weight Loss

Sep 5, 2024, 5:30 PM EDT - 10 months ago

Allurion Receives Continued Listing Standards Notice from NYSE

Sep 5, 2024, 8:00 AM EDT - 10 months ago

Allurion Announces Publication of New Data Demonstrating Weight Loss in Adolescents Suffering from Obesity

Sep 3, 2024, 8:00 AM EDT - 10 months ago

Allurion Announces the Appointment of Eli Lilly Veteran, Keith Johns, to Its Board of Directors

Aug 28, 2024, 8:28 AM EDT - 10 months ago

Allurion Announces Publication of New Data Demonstrating Continued Weight Loss at One Year On the Allurion Program

Aug 13, 2024, 10:18 AM EDT - 11 months ago

Allurion Technologies Inc. (ALUR) Q2 2024 Earnings Call Transcript

Aug 13, 2024, 8:00 AM EDT - 11 months ago

Allurion Reports Second Quarter 2024 Financial Results and Provides Business Update

Jul 16, 2024, 4:05 PM EDT - 1 year ago

Allurion to Report Second Quarter 2024 Financial Results on August 13, 2024

Jun 28, 2024, 9:06 AM EDT - 1 year ago

Allurion Announces Pricing of $20 million Public Offering and Concurrent Private Placement

Jun 26, 2024, 8:36 AM EDT - 1 year ago

Allurion Announces Launch of Offering of Common Stock and Warrants

Jun 20, 2024, 8:00 AM EDT - 1 year ago

Allurion Announces Publication of New Data Demonstrating Lean Mass Gains in Patients Experiencing 14% Weight Loss

Jun 11, 2024, 8:00 AM EDT - 1 year ago

Allurion Announces Three Scientific Presentations at the 40th Annual Meeting of the American Society for Metabolic and Bariatric Surgery

Jun 5, 2024, 8:00 AM EDT - 1 year ago

Allurion Announces the Appointment of Ojas A. Buch as Chief Operating Officer

May 30, 2024, 8:00 AM EDT - 1 year ago

Allurion Announces Expansion of AI Weight Loss Coach to Support Patients on GLP-1s

May 29, 2024, 4:05 PM EDT - 1 year ago

Allurion to Participate in Two Upcoming Investor Conferences in June 2024

Cattitude Jun. 26 at 11:00 PM

$ALUR sleeper 😎

0 · Reply

Blackberrry Jun. 25 at 10:21 PM

$ALUR what was that 150k share candle near the close? 🤔

1 · Reply

Dani_G_German Jun. 25 at 7:55 PM

$ALUR 👀

0 · Reply

Cattitude Jun. 25 at 7:52 PM

$ALUR lovely green candle 😎

0 · Reply

Cattitude Jun. 25 at 7:45 PM

$ALUR fda coming soon, idk if any of you listened last week at the conference, but they sounded super ready for launching in the us, was very intriguing and not to mention the insider buys 😎

1 · Reply

Stonehenge52 Jun. 25 at 4:06 PM

$ALUR always love these red days. Shorting is the only way with these medical stocks

1 · Reply

RollingDollars Jun. 23 at 7:15 PM

$ALUR

0 · Reply

KNCourt24 Jun. 23 at 4:21 PM

$ALUR Gonna have patience with this one EOM final module submission to FDA

0 · Reply

Stonehenge52 Jun. 20 at 8:20 PM

$ALUR any of yall starting to catch on yet?

0 · Reply

Stonehenge52 Jun. 20 at 2:25 PM

$ALUR medical stocks will almost certainly print you money if you short them.

0 · Reply

RAGC Jun. 18 at 11:15 PM

$ALUR news 👇👇 https://www.sec.gov/Archives/edgar/data/1964979/000119312525142801/d130343ds8.htm

0 · Reply

Stonehenge52 Jun. 18 at 9:45 PM

$ALUR beautiful drops in A.H. Making up for the fact it won’t be able to lose money tomorrow with the markets closest still possible to see $2.00 by start of next week.

0 · Reply

Cattitude Jun. 18 at 9:03 PM

$ALUR boy did I get screwed here lol, so we see this going back to the 3’s? Fml 🤦‍♀️ lol

1 · Reply

Stonehenge52 Jun. 18 at 8:12 PM

$ALUR should see some pretty consistent drops. This company hasn’t achieved anything and with little to no momentum or following the news will have little impact. It may spike but only will help increase short position. Typical medical stocks easy to short and quick to give up gains.

2 · Reply

KNCourt24 Jun. 18 at 5:29 PM

$ALUR also seems like the bottom around these levels. Reversal imminent. Final module submission within 2 weeks🚀

1 · Reply

Blackberrry Jun. 18 at 4:49 PM

$ALUR We are sitting on a gold mine and... we are in early. Its a good feeling when you have a guaranteed winner. Our swallowable poopable baloon works in tandem with GLP1- and without it. Something odd about having your stomach physically distended by a balloon causes your body to preserve muscle mass and even gain a little while obliterating fat. $HIMS $HUSA $RGC $OP

0 · Reply

BioRich Jun. 18 at 3:31 PM

$ALUR What's the Bear argument here? Currently no position but considering hopping in. Thanks in advance!

4 · Reply

Icantgetup Jun. 18 at 3:30 PM

$BON $ALUR $RSLS So let us know what you did with your "All In" on ALUR? Because it has not shown any bullish movement yet since I marked you.

1 · Reply

KNCourt24 Jun. 18 at 2:48 PM

$ALUR Final module submission to FDA within 2 weeks this will move a good amount I’ll be patient

0 · Reply

KNCourt24 Jun. 18 at 1:35 PM

$ALUR Only a matter of time..🚀

0 · Reply

Blackberrry Jun. 18 at 1:22 PM

$ALUR one of those tickers you wake up one day and its up 500% premarket $MLGO $EONR $HUSA $RBNE

0 · Reply

KNCourt24 Jun. 18 at 12:49 AM

$ALUR Great PR drop today with volume picked up this could get interesting next couple weeks with final module submission to FDA by end of June

0 · Reply

Market Cap	18.35M
Revenue (ttm)	32.11M
Net Income (ttm)	-26.15M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-81.44%
Debt to Equity Ratio	0.00

Volume	65,200
Avg Vol	379,198
Day's Range	N/A - N/A
Shares Out	7.46M
Stochastic %K	56%
Beta	-0.47
Analysts	Strong Sell
Price Target	$10.62